Analysis of Healthcare Resource Utilization and Costs after the Initiation of Biologic Treatment in Patients with Ulcerative Colitis and Crohn’s Disease
**Background:** This retrospective cohort study aimed to describe and quantify healthcare resource utilization and costs for patients with ulcerative colitis (UC) and Crohn’s disease (CD) following initiation of biologic therapy. **Methods:** Resource utilization and costs were analyzed at baseline...
Saved in:
Main Authors: | Sue Perera, Shibing Yang, Marni Stott-Miller, Joanne Brady |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2018-09-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/9791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Why Distinguish between Ulcerative Colitis and Crohn’s Disease?
by: Daniel Rachmilewitz
Published: (1989-01-01) -
Seasonal Pattern in the Relapses of Crohn's Disease and Ulcerative Colitis in British Columbia
by: Frank H Anderson, et al.
Published: (1995-01-01) -
Differential Intestinal Mucosa Transcriptomic Biomarkers for Crohn’s Disease and Ulcerative Colitis
by: Maria Dobre, et al.
Published: (2018-01-01) -
Unleashing the potential of extracellular vesicles for ulcerative colitis and Crohn's disease therapy
by: George Chigozie Njoku, et al.
Published: (2025-03-01) -
Cerebral Venous Thrombosis as an Initial Presentation of Ulcerative Colitis
by: Hiroshi Yamazaki, et al.
Published: (2022-01-01)